Research Topics

Integrated Cancer Centers represent the new model for the management of solid and haematological cancers all over the world. They integrate the different professionals into a vast system, which includes public health specialists, fundamental, translational and clinical research, as well as healthcare teams involved in diagnosis and treatment. The CRTOH adopted this innovated model, and is also part of an ambitious initiative taking place in Western Switzerland that aims to designates “poles of excellence”, to, ultimately, ensure the best possible care for patients.

Full Members

	Immunopharmacology of Cancer Prof. Carole Bourquin, Department of Anaesthesiology, Pharmacology, Intensive Care and Emergencies, Faculty of Medicine & Pharmaceutical Sciences, Faculty of Science
	Gynaecological Tumours and Development Biology Prof. Marie Cohen, Department of Paediatrics, Gynaecology and Obstetrics, Faculty of Medicine
	Population Genomics and Genetics of Complex Traits Prof. Emmanouil Dermitzakis, Department of Genetic Medicine and Development, Faculty of Medicine
	Cancer Immunotherapy Prof. Pierre-Yves Dietrich, Department of Medicine, Faculty of Medicine & Head of the Division of Oncology, HUG
	Molecular mechanisms of fatty liver disease progression to hepatocellular carcinoma Prof. Michelangelo Foti, Department of Cell Physiology and Metabolism, Faculty of Medicine
	Cell Division and Develoment Prof. Monica Gotta, Department of Cell Physiology and Metabolism, Faculty of Medicine
	Lymphatic vessels in the regulation of tumor immunity Prof. Stéphanie Hugues, Department of Pathology and Immunology, Faculty of Medicine
	Oncogenic signaling pathways: from fundamental research to drug discovery Vladimir Katanaev, Department of Cell Physiology and Metabolism, Faculty of Medicine
	Pathogenesis and precision medicine in breast and ovarian cancer Dr. Intidhar Labidi-Galy, Department of Medicine, Faculty of Medicine & Division of Oncology, HUG
	Lymphoma and Leukemia Prof. Thomas Matthes, Department of Medicine, Faculty of Medicine & Division of Haematology, HUG
	Translational Research in Oncology Prof. Nicolas Mach, Department of Medicine, Faculty of Medicine & in charge of Fondation Dr Henri Dubois-Ferrière Dinu Lipatti Clinical Research Unit, HUG
	Cell Division and Cancer Prof. Patrick Meraldi, Department of Cell Physiology and Metabolism, Faculty of Medicine
	Brain Tumor and Immune Cell Engineering Group – BTICE Group Prof. Denis Migliorini, ISERC Foundation Chair in Immunotherapies of Brain Tumours, Department of Medicine, Faculty of Medicine, Department of Oncology, HUG
	Understanding and manipulating the immune system to fight against cancer Prof. Mikäel PITTET, ISREC Foundation Chair in onco-immunology ,Department of Pathology and Immunology, Faculty of Medicine, Department of Oncology, HUG
	Lymphomas and leukaemias Prof. Jérôme Tamburini, Department of Medicine, Faculty of Medicine & Department of Oncology, HUG
	Precision oncology Dr. Petros Tsantoulis, Department of Medicine, Faculty of Medicine & Department of Oncology, HUG
	Liver Cancer Prof. Christian Toso, Department of Surgery, Faculty of Medicine & Division of Transplant Surgery, HUG
	Immunobiology of Brain Tumours Dr Paul Walker, Department of Medicine, Faculty of Medicine & Division of Oncology, HUG

Associated Members

	Biopharmaceuticals Prof. Gerrit Borchard, Pharmaceutical Sciences, Faculty of Science
	Molecular Pharmacology Prof. Patrycja Nowak-Sliwinska, Pharmaceutical Sciences, Faculty of Science
	Pharmacognosy Prof. Muriel Cuendet, Pharmaceutical Sciences, Faculty of Science